The effect of TIPEK(EGF) on the Cultivation of Penaeus Vannamei

Views : 405
Author : Rota
Update time : 2024-12-10 15:27:03

The effect of TIPEK(EGF) on the Cultivation of Penaeus Vannamei

 

1. Objective of the Trial

The purpose of this trial is to add the product "TIPEK(EGF)" to the feed in order to verify its effects in promoting the repair of inTrialinal epithelial damage, growth and development, enhancing the digestive and absorptive capacity of the inTrialine, improving the inTrialinal immune function, comprehensively enhancing the overall health of the animal body, and facilitating growth.

 

2. Trial Period

Trial Timeline: From September 5, 2024, to October 16, 2024

Duration of Trial: Preparation Phase - 19 days; Formal Trial Phase - 23 days

 

3. Trial Design

3.1Trial Materials

Trial Animals: 50-day-old Pacific White Shrimp (Litopenaeus vannamei)

The Trial animals should be of pure genetic lineage, with a clear source, healthy, and of uniform size from the same batch. The sex ratio (male to female) should remain consistent across all replicates.

3.2Trial Groups

Table 1

Items

Treatments

Sample Number

Control Group

Basal Ration

36000×2

Trial Group

Basal Ration+5kg/t 10% TIPEK(EGF)

36000×2

3.3 Trial Management
3.3.1 During the trial, feeding and management practices should adhere to the breeding standards of the aquaculture farm.
3.3.2 The water quality conditions across all replicates should remain consistent.
3.3.3 With the exception of routine immunization procedures synchronized with other shrimp populations, maintaining the trial treatment as the sole variable is the principle to follow.

3.4 Sample Collection and Indicator Measurement
During the trial, shrimp size was regularly measured and marked weekly. After a 24-hour fasting period following the trial, the shrimp were weighed upon harvest from the pond, with a final marking conducted prior to harvest. Feeding records were maintained throughout the trial period. Upon completion of the growth trial, the total weight of shrimp from each replicate trial was tallied, and indicators such as size, average final weight, and survival rate were calculated. Following the trial, three shrimp from each group were randomly selected, individually measured for body length and weighed, and then dissected to remove the hepatopancreas, which was weighed before being placed in a cryopreservation tube. The hepatopancreas weight, body length, and body weight data were used to calculate indicators such as hepatosomatic index (HSI) and condition factor (K).


Method for Measuring Body Length: A ruler was used to measure the length from the base of the shrimp's eyestalk to the end of its tail segment.
Average Final Weight = Marked Weight / Number of Marked Shrimp
Survival Rate = Total Weight / Average Final Weight / 36,000
Size = Number of Marked Shrimp / Marked Weight × 500
Hepatosomatic Index (HSI, %) = 100 × Hepatopancreas Weight / Shrimp Body Weight
Condition Factor (K) = Body Weight / (Body Length)^3
Additionally, photographs of the shrimp's conditions were taken weekly to maintain a health record.

 

4.  Data Processing and Statistical Analysis

The trial data were initially summarized using Excel. The t-Trial analysis of the results was conducted using SPSS 19.0 statistical software (with P < 0.05 indicating a statistically significant difference). The trial data are presented as "mean ± standard deviation."

 

5.  Result and Anaysis

5.1  Surface observation

 

5.2  Growth Index

Table 2 Trial Result

 

Control Group

Trial Group

D-value

Incremental percentage

Initial Size

153.23

158.53

5.3

3.46

Final Size

89.48

89.30

-0.18

-0.20

Growth Size

63.75

69.23

5.48

8.60

Initial Weight/g

3.26

3.15

-0.11

-3.37

Final Weight/g

5.60

5.62

0.02

0.36

Average Weight Gain/g

2.34

2.47

0.13

5.56

Body Length/cm

7.97

8.97

1

12.55

Condition Factor

4.53

6.27

1.74

38.41

Liver-to-Body Ratio%

3.75

6.17

2.42

64.53

Average Feed Intake per Pond/kg

59.55

57.63

-1.92

-3.22

FCR

0.86

0.77

-0.09

-10.47

Survival Rate%

82.08

84.17

2.09

2.55

 

As shown in Table 2, the trial group significantly improved the growth performance of the Pacific white shrimp. Specifically, the growth specification of the trial group was 8.6% higher than that of the control group, and the average weight gain was 5.56% higher. Additionally, the body length, condition factor, and hepatosomatic index of the trial group were 12.55%, 38.41%, and 64.53% higher, respectively, compared to the control group. The survival rate of the trial group was also 2.55% higher. Meanwhile, the feed conversion ratio of the trial group was 10.47% lower than that of the control group.

 

6. Trial Conclusion

The trial group can promote the healthy development of the white shrimp (Litopenaeus vannamei) and significantly improve their growth performance.




Related News
Read More >>
Article Sharing | Interactions Between the Porcine Host and Gut Microbiota — The impact of gut microbiota on the host immune system Ⅱ Article Sharing | Interactions Between the Porcine Host and Gut Microbiota — The impact of gut microbiota on the host immune system Ⅱ
Apr .30.2026
Here is a **concise, journal-style introduction (a few sentences)**:

---

Commensal gut microbiota play a fundamental role in the development and regulation of host immunity in mammals. Disruption of the microbiota–immune balance leads to dysbiosis, which is closely associated with increased disease susceptibility. In contrast, the establishment of a stable and defined microbial community supports the maturation of immune functions. Among these, lactic acid bacteria have attracted significant attention due to their strain-specific ability to modulate immune responses and enhance host defense mechanisms.
Article Shareing | Interactions Between the Porcine Host and Gut Microbiota — The impact of gut microbiota on the host immune system Article Shareing | Interactions Between the Porcine Host and Gut Microbiota — The impact of gut microbiota on the host immune system
Apr .07.2026
Pigs are the only animal susceptible to human rotavirus (HRV)-induced diarrhea, making them an important model for studying host-microbe interactions. Studies in gnotobiotic pigs show that probiotic colonization with Lactobacillus rhamnosus GG and Bifidobacterium animalis Bb12 enhances HRV-specific IgA responses and reduces diarrhea severity. Similarly, colonization with the simplified Bristol microbiota upregulates serum IgA and IgM levels, supporting intestinal and systemic immune development in newborn pigs. These findings highlight the potential of gut microbiota interventions to modulate immunity and improve pig health.
Article Sharing | Interactions Between the Porcine Host and Gut Microbiota — The Role of Antibiotics Article Sharing | Interactions Between the Porcine Host and Gut Microbiota — The Role of Antibiotics
Mar .18.2026
Antibiotics are widely used in pig production to prevent disease and promote growth. However, their use can disrupt the gut microbiota, reduce beneficial bacteria, and increase opportunistic pathogens. These changes may affect intestinal health, immune function, and the spread of antibiotic resistance genes.
HUADE VOICE| The Festive Spirit Lingers — Life at Huade HUADE VOICE| The Festive Spirit Lingers — Life at Huade
Mar .17.2026
The Lunar New Year may be nearing its end, but the festive spirit is still in the air.